Sarah Louise Rowland-jones

Sarah Louise Rowland-jones's AcademicInfluence.com Rankings

Biology

#8883

World Rank

#12021

Historical Rank

Virology

#200

World Rank

#206

Historical Rank

Evolutionary Biology

#205

World Rank

#226

Historical Rank

Microbiology

#463

World Rank

#524

Historical Rank

biology Degrees

Download Badge

Biology

Sarah Louise Rowland-jones's Degrees

PhD Virology University of Oxford

Why Is Sarah Louise Rowland-jones Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Sarah Louise Rowland-jones's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus (2020) (3171)
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections (2002) (1736)
Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. (1998) (1566)
Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS (1997) (1280)
Skewed maturation of memory HIV-specific CD8 T lymphocytes (2001) (1157)
Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition (1991) (1068)
HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function (2000) (1010)
HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women (1995) (849)
Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever (2003) (815)
Cellular immune responses to HIV (2001) (683)
A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. (1999) (571)
Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G (2003) (538)
Characterization of CD4+ CTLs Ex Vivo1 (2002) (517)
Clustered Mutations in HIV-1 Gag Are Consistently Required for Escape from Hla-B27–Restricted Cytotoxic T Lymphocyte Responses (2001) (504)
Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 Infection (2004) (463)
Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. (2008) (446)
Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants (1994) (443)
Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. (1998) (437)
HIV-1-Specific Mucosal CD8+ Lymphocyte Responses in the Cervix of HIV-1-Resistant Prostitutes in Nairobi1 (2000) (412)
HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant (1993) (398)
Decay Kinetics of Human Immunodeficiency Virus-Specific Effector Cytotoxic T Lymphocytes after Combination Antiretroviral Therapy (1999) (388)
Antigenic oscillations and shifting immunodominance in HIV-1 infections (1995) (357)
Recognition of HLA‐A3 and HLA‐A11 by KIR3DL2 is peptide‐specific (2004) (323)
Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies. (1999) (290)
Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection. (2000) (279)
Mature CD8(+) T lymphocyte response to viral infection during fetal life. (2003) (264)
Cutting Edge: Allele-Specific and Peptide-Dependent Interactions between KIR3DL1 and HLA-A and HLA-B12 (2007) (251)
Polyfunctional T cell responses are a hallmark of HIV‐2 infection (2008) (247)
Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses. (2001) (239)
CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects. (2001) (239)
A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans. (2004) (236)
HIV-2: the forgotten AIDS virus. (2008) (221)
Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells. (2002) (219)
Progress towards a dengue vaccine. (2009) (213)
Immune responses in HIV-exposed seronegatives: have they repelled the virus? (1995) (205)
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine (2021) (191)
Comparing HIV‐1 and HIV‐2 infection: Lessons for viral immunopathogenesis (2013) (187)
Oligoclonal Expansions of CD8+ T Cells in Chronic HIV Infection Are Antigen Specific (1998) (186)
Demystified . . . Human endogenous retroviruses (2003) (186)
Premature ageing of the immune system: the cause of AIDS? (2002) (185)
Increased Expression of the NK Cell Receptor KLRG1 by Virus-Specific CD8 T Cells during Persistent Antigen Stimulation (2005) (171)
Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. (1995) (166)
Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection (2000) (165)
Lessons from the study of T-cell differentiation in persistent human virus infection. (2004) (157)
Role of cellular immunity in protection against HIV infection. (1997) (151)
Recombination following superinfection by HIV-1 (2004) (135)
Out of Africa: what can we learn from HIV-2 about protective immunity to HIV-1? (2007) (134)
Rapid death of adoptively transferred T cells in acquired immunodeficiency syndrome. (1999) (134)
Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57 (2002) (133)
Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers. (2006) (133)
HIV-specific Cytotoxic T Cells from Long-Term Survivors Select a Unique T Cell Receptor (2004) (129)
HLA-A2 subtypes are functionally distinct in peptide binding and presentation (1995) (120)
Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors. (1999) (115)
Strong Human Immunodeficiency Virus (HIV)-Specific Cytotoxic T-Lymphocyte Activity in Sydney Blood Bank Cohort Patients Infected with nef-Defective HIV Type 1 (1999) (113)
Cytomegalovirus Infection in Gambian Infants Leads to Profound CD8 T-Cell Differentiation (2007) (111)
A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides (1993) (111)
Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV (2005) (109)
The assessment of antigen-specific CD8+ T cells through the combination of MHC class I tetramer and intracellular staining. (2002) (109)
Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa (2010) (107)
Maintenance of HIV-Specific CD4+ T Cell Help Distinguishes HIV-2 from HIV-1 Infection1 (2006) (107)
New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers. (2001) (105)
High Pro-Inflammatory Cytokine Secretion and Loss of High Avidity Cross-Reactive Cytotoxic T-Cells during the Course of Secondary Dengue Virus Infection (2007) (101)
Expansion and Diversification of Virus-Specific T Cells following Immunization of Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Individuals with a Recombinant Modified Vaccinia Virus Ankara/HIV-1 Gag Vaccine (2006) (94)
Optimization of a peptide-based protocol employing IL-7 for in vitro restimulation of human cytotoxic T lymphocyte precursors. (1997) (94)
Different MHC class I alleles compete for presentation of overlapping viral epitopes. (1995) (92)
Timing of CD8+ T Cell Responses in Relation to Commencement of Capillary Leakage in Children with Dengue (2010) (90)
Virological and immunological correlates of mother-to-child transmission of cytomegalovirus in The Gambia. (2008) (90)
Dynamics of T Cell Responses in HIV Infection1 (2002) (89)
Acute cytomegalovirus infection in Kenyan HIV-infected infants (2009) (88)
HLA‐C as a mediator of natural killer and T‐cell activation: spectator or key player? (2011) (88)
Polyfunctional CD4+ and CD8+ T Cell Responses to Tuberculosis Antigens in HIV-1–Infected Patients before and after Anti-Retroviral Treatment (2010) (88)
Association between maternal and infant class I and II HLA alleles and of their concordance with the risk of perinatal HIV type 1 transmission. (2002) (87)
Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection. (2007) (87)
A call for randomized controlled trials of antiretroviral therapy for HIV-2 infection in West Africa. (2008) (85)
Delaying Bacillus Calmette-Guérin Vaccination from Birth to 4 1/2 Months of Age Reduces Postvaccination Th1 and IL-17 Responses but Leads to Comparable Mycobacterial Responses at 9 Months of Age (2010) (85)
Distinct Recognition of Non-Clade B Human Immunodeficiency Virus Type 1 Epitopes by Cytotoxic T Lymphocytes Generated from Donors Infected in Africa (1999) (83)
Chemokine receptor polymorphisms and human immunodeficiency virus disease progression. (1999) (82)
Anti-HIV cellular immunity: recent advances towards vaccine design. (1999) (81)
How important is the 'quality' of the cytotoxic T lymphocyte (CTL) response in protection against HIV infection? (2001) (81)
HMOX1 Gene Promoter Alleles and High HO-1 Levels Are Associated with Severe Malaria in Gambian Children (2012) (80)
Risk Factors for and Clinical Outcome of Congenital Cytomegalovirus Infection in a Peri-Urban West-African Birth Cohort (2007) (80)
Structures of Three HIV-1 HLA-B*5703-Peptide Complexes and Identification of Related HLAs Potentially Associated with Long-Term Nonprogression12 (2005) (80)
Lack of KIR3DS1 binding to MHC class I Bw4 tetramers in complex with CD8+ T cell epitopes. (2007) (78)
Maternal HLA homozygosity and mother-child HLA concordance increase the risk of vertical transmission of HIV-1. (2008) (77)
The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design (2020) (77)
Early Virological and Immunological Events in Asymptomatic Epstein-Barr Virus Infection in African Children (2015) (74)
Dynamics of T Cell Responses in HIV Infection (2002) (72)
Human leukocyte antigen (HLA) B*18 and protection against mother-to-child HIV type 1 transmission. (2004) (71)
HIV Type 1 Resistance in Kenyan Sex Workers Is Not Associated with Altered Cellular Susceptibility to HIV Type 1 Infection or Enhanced β-Chemokine Production (1998) (69)
AIDS pathogenesis: what have two decades of HIV research taught us? (2003) (69)
Two Distinct Epidemics: The Rise of HIV-1 and Decline of HIV-2 Infection Between 1990 and 2007 in Rural Guinea-Bissau (2009) (69)
Differences in peptide presentation between B27 subtypes: the importance of the P1 side chain in maintaining high affinity peptide binding to B*2703. (1994) (66)
Longitudinal Assessment of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Gamma Interferon Responses during the First Year of Life in HIV-1-Infected Infants (2005) (63)
Strong TCR Conservation and Altered T Cell Cross-Reactivity Characterize a B*57-Restricted Immune Response in HIV-1 Infection12 (2006) (63)
Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians (2010) (62)
Dimorphic Motifs in D0 and D1+D2 Domains of Killer Cell Ig-Like Receptor 3DL1 Combine to Form Receptors with High, Moderate, and No Avidity for the Complex of a Peptide Derived from HIV and HLA-A*24021 (2009) (61)
Antigen–specific release of β-chemokines by anti-HIV-1 cytotoxic T lymphocytes (1998) (61)
New Insights into Host Factors in HIV-1 Pathogenesis (2001) (61)
Examination of Influenza Specific T Cell Responses after Influenza Virus Challenge in Individuals Vaccinated with MVA-NP+M1 Vaccine (2013) (60)
Direct relationship between virus load and systemic immune activation in HIV-2 infection. (2010) (59)
Virological Response to Highly Active Antiretroviral Therapy in Patients Infected with Human Immunodeficiency Virus Type 2 (HIV-2) and in Patients Dually Infected with HIV-1 and HIV-2 in The Gambia and Emergence of Drug-Resistant Variants (2009) (58)
The effect of placental malaria infection on cord blood and maternal immunoregulatory responses at birth (2010) (58)
HIV infection: where have all the T cells gone? (1999) (57)
Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource Settings (2011) (56)
Multilayered Defense in HLA-B51–Associated HIV Viral Control (2011) (54)
Long-term follow-up of HIV-2-related AIDS and mortality in Guinea-Bissau: a prospective open cohort study. (2018) (54)
Immunogenicity of the Tuberculosis Vaccine MVA85A Is Reduced by Coadministration with EPI Vaccines in a Randomized Controlled Trial in Gambian Infants (2011) (54)
Potent Autologous and Heterologous Neutralizing Antibody Responses Occur in HIV-2 Infection across a Broad Range of Infection Outcomes (2011) (53)
Cytomegalovirus infection induces T‐cell differentiation without impairing antigen‐specific responses in Gambian infants (2008) (53)
Mutation of the alpha 2 domain disulfide bridge of the class I molecule HLA-A*0201. Effect on maturation and peptide presentation. (1994) (52)
Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide. (1993) (52)
Correlates of T-cell-mediated viral control and phenotype of CD8(+) T cells in HIV-2, a naturally contained human retroviral infection. (2013) (51)
The detection of cytomegalovirus DNA in maternal plasma is associated with mortality in HIV-1-infected women and their infants (2009) (51)
T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study (2021) (51)
Dendritic Cells Are Less Susceptible to Human Immunodeficiency Virus Type 2 (HIV-2) Infection than to HIV-1 Infection (2007) (50)
Maintenance of Large Subpopulations of Differentiated CD8 T-Cells Two Years after Cytomegalovirus Infection in Gambian Infants (2008) (49)
High Frequency of HIV Mutations Associated with HLA-C Suggests Enhanced HLA-C–Restricted CTL Selective Pressure Associated with an AIDS-Protective Polymorphism (2012) (49)
Viral coinfections among African children infected with human immunodeficiency virus type 1. (2003) (48)
HIV-2 capsids distinguish high and low virus load patients in a West African community cohort. (2009) (48)
CCR5 promoter polymorphisms in a Kenyan perinatal human immunodeficiency virus type 1 cohort: association with increased 2-year maternal mortality. (2001) (48)
Chronic lung disease in HIV-infected children established on antiretroviral therapy (2016) (47)
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV (2021) (47)
Quantitative ex vivo analysis of functional virus-specific CD8 T lymphocytes in the blood and genital tract of HIV-infected women (2003) (47)
Influence of HLA Class I and HLA-KIR Compound Genotypes on HIV-2 Infection and Markers of Disease Progression in a Manjako Community in West Africa (2010) (46)
Mortality and immunovirological outcomes on antiretroviral therapy in HIV-1 and HIV-2-infected individuals in the Gambia (2011) (46)
Therapeutic immunization of highly active antiretroviral therapy-treated HIV-1-infected patients: safety and immunogenicity of an HIV-1 gag/poly-epitope DNA vaccine (2005) (45)
HV-1-specific cytotoxic T lymphocytes and breast milk HIV-1 transmission. (2009) (45)
The impact of viral mutations on recognition by SARS-CoV-2 specific T cells (2021) (45)
Screening for HIV-specific T-cell responses using overlapping 15-mer peptide pools or optimized epitopes (2004) (45)
Extensive HLA-driven viral diversity following a narrow-source HIV-1 outbreak in rural China. (2011) (43)
The Tuberculin Skin Test (TST) Is Affected by Recent BCG Vaccination but Not by Exposure to Non-Tuberculosis Mycobacteria (NTM) during Early Life (2010) (43)
HIV-1 Env-specific cytotoxic T-lymphocyte responses in exposed, uninfected Kenyan sex workers: a prospective analysis (2004) (43)
The impact of HIV-1 infection and exposure on natural killer (NK) cell phenotype in Kenyan infants during the first year of life (2012) (41)
Natural Killer Cell Function Is Well Preserved in Asymptomatic Human Immunodeficiency Virus Type 2 (HIV-2) Infection but Similar to That of HIV-1 Infection When CD4 T-Cell Counts Fall (2006) (41)
Functional Discrepancies in HIV-Specific CD8+ T-Lymphocyte Populations Are Related to Plasma Virus Load (2002) (40)
Will SARS-CoV-2 Infection Elicit Long-Lasting Protective or Sterilising Immunity? Implications for Vaccine Strategies (2020) (2020) (40)
HIV-2 and T cell recognition. (1998) (40)
HIV-1 transmission and acute HIV-1 infection. (2001) (39)
Identification of H5N1-specific T-cell responses in a high-risk cohort in vietnam indicates the existence of potential asymptomatic infections. (2012) (39)
Antigen-specific release of beta-chemokines by anti-HIV-1 cytotoxic T lymphocytes. (1998) (39)
The role of cytotoxic T-cells in HIV infection. (1998) (39)
An antigen processing polymorphism revealed by HLA‐B8‐restricted cytotoxic T lymphocytes which does not correlate with TAP gene polymorphism (1993) (38)
Efficient Nef-Mediated Downmodulation of TCR-CD3 and CD28 Is Associated with High CD4+ T Cell Counts in Viremic HIV-2 Infection (2012) (38)
Mycobacterial T cell responses in HIV-infected patients with advanced immunosuppression. (2008) (37)
Sex-Differential Non-Vaccine-Specific Immunological Effects of Diphtheria-Tetanus-Pertussis and Measles Vaccination. (2016) (37)
Epstein-Barr Virus but Not Cytomegalovirus Is Associated with Reduced Vaccine Antibody Responses in Gambian Infants (2010) (37)
Human leucocyte antigen supertypes and immune susceptibility to HIV-1, implications for vaccine design. (2001) (36)
Omicron entry route (2022) (36)
CD4(+) T cell responses to cytomegalovirus in early life: a prospective birth cohort study. (2008) (36)
Virological and immunological response to Combivir and emergence of drug resistance mutations in a cohort of HIV-2 patients in The Gambia (2006) (36)
Immunological impact of an additional early measles vaccine in Gambian children: Responses to a boost at 3 years (2012) (35)
Highly avid, oligoclonal, early‐differentiated antigen‐specific CD8+ T cells in chronic HIV‐2 infection (2010) (35)
HTLV-1 in rural Guinea-Bissau: prevalence, incidence and a continued association with HIV between 1990 and 2007 (2010) (34)
Immunisation with recombinant modified vaccinia virus Ankara expressing HIV‐1 gag in HIV‐1‐infected subjects stimulates broad functional CD4+ T cell responses (2006) (34)
Persistent HIV-1-specific cellular responses despite prolonged therapeutic viral suppression (2002) (33)
Outcomes of prevention of mother to child transmission of the human immunodeficiency virus-1 in rural Kenya—a cohort study (2015) (33)
HTLV-1 and HIV-2 Infection Are Associated with Increased Mortality in a Rural West African Community (2011) (33)
Lymphocytes : a practical approach (2000) (32)
Gonococcal cervicitis is associated with reduced systemic CD8+ T cell responses in human immunodeficiency virus type 1-infected and exposed, uninfected sex workers. (2002) (32)
CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV‐2) and type 1 (HIV‐1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype (2005) (32)
Acute Cytomegalovirus Infection Is Associated with Increased Frequencies of Activated and Apoptosis-Vulnerable T Cells in HIV-1-Infected Infants (2012) (32)
The T cell surface--how well do we know it? (2003) (32)
Recombinant Salmonella typhimurium strains that invade nonphagocytic cells are resistant to recognition by antigen-specific cytotoxic T lymphocytes (1992) (31)
Placental Malaria is associated with reduced early life weight development of affected children independent of low birth weight (2010) (31)
Correlates of Delayed Disease Progression in HIV-1-Infected Kenyan Children1 (2005) (31)
Characterization of an HLA‐C‐restricted CTL response in chronic HIV infection (2010) (31)
Tenets of protection from progression to AIDS: lessons from the immune responses to HIV-2 infection (2008) (31)
Structural features underlying T-cell receptor sensitivity to concealed MHC class I micropolymorphisms (2012) (30)
Long-term survivors in Nairobi: complete HIV-1 RNA sequences and immunogenetic associations. (2004) (30)
Naturally occurring A pocket polymorphism in HLA-B*2703 increases the dependence on an accessory anchor residue at P1 for optimal binding of nonamer peptides. (1997) (29)
Functions of tetramer-stained HIV-specific CD4(+) and CD8(+) T cells. (2000) (29)
Preservation of a critical epitope core region is associated with the high degree of flaviviral cross‐reactivity exhibited by a dengue‐specific CD4+ T cell clone (2008) (29)
Altered Memory T-Cell Responses to Bacillus Calmette-Guerin and Tetanus Toxoid Vaccination and Altered Cytokine Responses to Polyclonal Stimulation in HIV-Exposed Uninfected Kenyan Infants (2015) (28)
Breast milk cellular HIV-specific interferon &ggr; responses are associated with protection from peripartum HIV transmission (2012) (28)
Population dynamics of HIV-2 in rural West Africa: comparison with HIV-1 and ongoing transmission at the heart of the epidemic (2013) (28)
Are Plasma Biomarkers of Immune Activation Predictive of HIV Progression: A Longitudinal Comparison and Analyses in HIV-1 and HIV-2 Infections? (2012) (27)
Interactions between malaria and HIV infection-an emerging public health problem? (2002) (27)
Effects of cryopreservation on CD4+ CD25+ T cells of HIV‐1 infected individuals (2008) (27)
Prevalence and magnitude of human immunodeficiency virus (HIV) type 1-specific lymphocyte responses in breast milk from HIV-1-seropositive women. (2003) (27)
Dual infection with HIV‑1 and HIV‑2: double trouble or destructive interference? (2010) (27)
HIV type 1 resistance in Kenyan sex workers is not associated with altered cellular susceptibility to HIV type 1 infection or enhanced beta-chemokine production. (1998) (27)
Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV (2021) (27)
Generation of a novel SARS-CoV-2 sub-genomic RNA due to the R203K/G204R variant in nucleocapsid: homologous recombination has potential to change SARS-CoV-2 at both protein and RNA level (2020) (27)
Aberrant natural killer (NK) cell activation and dysfunction among ART-treated HIV-infected adults in an African cohort (2019) (27)
Reciprocal recognition of an HLA-Cw4-restricted HIV-1 gp120 epitope by CD8+ T cells and NK cells (2009) (26)
Epitope Mapping of Broadly Neutralizing HIV-2 Human Monoclonal Antibodies (2012) (26)
Chronic comorbidities in children and adolescents with perinatally acquired HIV infection in sub-Saharan Africa in the era of antiretroviral therapy. (2020) (26)
Deep analysis of cellular transcriptomes – LongSAGE versus classic MPSS (2007) (26)
Sustained T Cell Immunity, Protection and Boosting Using Extended Dosing Intervals of BNT162b2 mRNA Vaccine (2021) (25)
HIV‐specific cytotoxic T‐cell activity in an HIV‐exposed but uninfected infants (1993) (25)
Cytomegalovirus Infection May Contribute to the Reduced Immune Function, Growth, Development, and Health of HIV-Exposed, Uninfected African Children (2016) (25)
Generation of a Novel SARS-CoV-2 Sub-genomic RNA Due to the R203K/G204R Variant in Nucleocapsid: Homologous Recombination has Potential to Change SARS-CoV-2 at Both Protein and RNA Level (2021) (24)
Recent advances in understanding HIV evolution (2017) (24)
Long-term non-progression in HIV infection: clinico pathological issues. (1999) (23)
Modified vaccinia Ankara expressing HIVA antigen stimulates HIV-1-specific CD8 T cells in ELISpot assays of HIV-1 exposed infants. (2005) (23)
HIV-1 Subtype A Gag Variability and Epitope Evolution (2014) (23)
Changing oral vaccine to inactivated polio vaccine might increase mortality (2016) (23)
Azithromycin versus placebo for the treatment of HIV-associated chronic lung disease in children and adolescents (BREATHE trial): study protocol for a randomised controlled trial (2017) (23)
The Antiviral Efficacy of HIV-Specific CD8+ T-Cells to a Conserved Epitope Is Heavily Dependent on the Infecting HIV-1 Isolate (2011) (22)
HIV and chemokine binding to red blood cells--DARC matters. (2008) (22)
Human immunodeficiency virus variants that escape cytotoxic T-cell recognition. (1992) (22)
Analysis of transition from long-term nonprogressive to progressive infection identifies sequences that may attenuate HIV type 1. (2001) (22)
Cytotoxic t lymphocytes in hiv infection (1993) (22)
Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa (2011) (22)
A Phase I Randomized Clinical Trial of Candidate Human Immunodeficiency Virus type 1 Vaccine MVA.HIVA Administered to Gambian Infants (2013) (20)
Parenteral exposure to high HIV viremia leads to virus‐specific T cell priming without evidence of infection (2004) (19)
Distinct recognition of closely-related HIV-1 and HIV-2 cytotoxic T-cell epitopes presented by HLA-B*2703 and B*2705. (1998) (19)
Four novel cytotoxic T-lymphocyte epitopes in the highly conserved major homology region of HIV-1 Gag, restricted through B*4402, B*1801, A*2601, B*70 (B*1509) (1998) (19)
Effects of Antenatal and Postnatal Environments on CD4 T-Cell Responses to Mycobacterium bovis BCG in Healthy Infants in The Gambia (2008) (19)
Cytomegalovirus viraemia is associated with poor growth and T-cell activation with an increased burden in HIV-exposed uninfected infants (2017) (19)
HLA typing in a Kenyan cohort identifies novel class I alleles that restrict cytotoxic T-cell responses to local HIV-1 clades (2002) (19)
Downregulation of the T-Cell Receptor by Human Immunodeficiency Virus Type 2 Nef Does Not Protect against Disease Progression (2009) (18)
Immune Reconstitution Inflammatory Syndrome and the Influence of T Regulatory Cells: A Cohort Study in the Gambia (2012) (18)
Phenotypic Characterization of HIV-Specific CD8+ T Cells during Early and Chronic Infant HIV-1 Infection (2011) (17)
Transition From Long-Term Nonprogression to HIV-1 Disease Associated With Escape From Cellular Immune Control (2008) (17)
Composition of Gut Microbiota of Children and Adolescents With Perinatal Human Immunodeficiency Virus Infection Taking Antiretroviral Therapy in Zimbabwe (2019) (17)
HLA Correlates of Long-Term Survival in Vertically Infected HIV-1-Positive Adolescents in Harare, Zimbabwe (2015) (16)
HIV-1 and AIDS: what are protective immune responses? (2002) (16)
HIV-2 as a model to identify a functional HIV cure (2019) (16)
An underestimated lentivirus model: what can HIV-2 research contribute to the development of an effective HIV-1 vaccine? (2011) (16)
Effect of Once-Weekly Azithromycin vs Placebo in Children With HIV-Associated Chronic Lung Disease (2020) (16)
AIDS in Africa: a disaster no longer waiting to happen (2000) (15)
Application of a Novel, Rapid, and Sensitive Oligonucleotide Ligation Assay for Detection of Cancer-Predicting Mutations in the Precore and Basal Core Promoter of Hepatitis B Virus (2008) (15)
How does the humoral response to HIV-2 infection differ from HIV-1 and can this explain the distinct natural history of infection with these two human retroviruses? (2015) (15)
HIV: Bad news for stop–start therapy? (2002) (15)
Preservation of Lymphopoietic Potential and Virus Suppressive Capacity by CD8+ T Cells in HIV-2–Infected Controllers (2016) (15)
CCR2-64I Polymorphism Is Associated With Lower Maternal HIV-1 Viral Load and Reduced Vertical HIV-1 Transmission (2009) (14)
Epidemiology of Cytomegalovirus among pregnant women in Africa. (2019) (14)
Predicting the extinction of HIV-2 in rural Guinea-Bissau (2015) (14)
Characterization of Melan-A reactive memory CD8+ T cells in a healthy donor. (2008) (14)
Unexpectedly High Prevalence of Cytomegalovirus DNAemia in Older Children and Adolescents With Perinatally Acquired Human Immunodeficiency Virus Infection (2019) (14)
HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form (2010) (14)
Article Commentary: Novel Agents for the Treatment of HIV-2 Infection (2012) (13)
P17-28 LB. The antiviral efficacy of HIV-specific CD8+ T-cells to a conserved epitope is heavily dependent on the infecting HIV-1 isolate (2009) (13)
Protective immunity against HIV infection: lessons from HIV-2 infection. (2006) (13)
Infants with late breast milk acquisition of HIV‐1 generate interferon‐gamma responses more rapidly than infants with early peripartum acquisition (2009) (13)
Comprehensive analysis of HIV Gag‐specific IFN‐γ response in HIV‐1‐ and HIV‐2‐infected asymptomatic patients from a clinical cohort in The Gambia (2008) (13)
The HIV protease inhibitor Indinavir reduces immature dendritic cell transendothelial migration (2003) (13)
A Novel Immunodominant CD8+ T Cell Response Restricted by a Common HLA-C Allele Targets a Conserved Region of Gag HIV-1 Clade CRF01_AE Infected Thais (2011) (13)
HIV-1 progression links with viral genetic variability and subtype, and patient’s HLA type: analysis of a Nairobi-Kenyan cohort (2014) (12)
Snapin promotes HIV‐1 transmission from dendritic cells by dampening TLR8 signaling (2017) (12)
Corynebacterium pseudodiphtheriticum--a skin pathogen. (1999) (12)
Viral Evolution and Cytotoxic T Cell Restricted Selection in Acute Infant HIV-1 Infection (2016) (12)
Immune-based approaches to the prevention of mother-to-child transmission of HIV-1: active and passive immunization. (2010) (12)
Dying T cells trigger autoimmunity in HIV (2007) (11)
Development and Evaluation of an Oligonucleotide Ligation Assay for Detection of Drug Resistance-Associated Mutations in the Human Immunodeficiency Virus Type 2 pol Gene (2007) (11)
Presence of a multidrug-resistance mutation in an HIV-2 variant infecting a treatment-naive individual in Caio, Guinea Bissau. (2009) (11)
Clinical Outcome of HIV Viraemic Controllers and Noncontrollers with Normal CD4 Counts Is Exclusively Determined by Antigen-Specific CD8+ T-Cell-Mediated HIV Suppression (2015) (11)
Negative Correlation between Circulating CD4+FOXP3+CD127− Regulatory T Cells and Subsequent Antibody Responses to Infant Measles Vaccine but Not Diphtheria–Tetanus–Pertussis Vaccine Implies a Regulatory Role (2017) (11)
Creating HIV-1 reverse transcriptase cytotoxic T lymphocyte target structures by HLA-A2 heavy chain modifications. (2000) (11)
Erratum: HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women (Nature Medicine 1, 59-64, (1995)) (1995) (11)
Prostitutes in Nairobi Responses in the Cervix of HIV-1-Resistant Lymphocyte + HIV-1-Specific Mucosal CD 8 (2000) (11)
Genome-wide profiling of humoral immunity and pathogen genes under selection identifies immune evasion tactics of Chlamydia trachomatis during ocular infection (2017) (11)
Resisting Immune Exhaustion in HIV-1 Infection (2008) (10)
The role of chemokine receptors in HIV infection. (1999) (10)
Functional Differences Exist between TNFα Promoters Encoding the Common −237G SNP and the Rarer HLA-B*5701-Linked A Variant (2012) (10)
Effect of antiretroviral therapy on longitudinal lung function trends in older children and adolescents with HIV-infection (2019) (9)
CD4+ cell count recovery following initiation of HIV antiretroviral therapy in older childhood and adolescence (2018) (9)
KIR content genotypes associate with carriage of hepatitis B surface antigen, e antigen and HBV viral load in Gambians (2017) (9)
Revisiting the Effect of Acute P. falciparum Malaria on Epstein-Barr Virus: Host Balance in the Setting of Reduced Malaria Endemicity (2012) (9)
Minimal Sex-Differential Modulation of Reactivity to Pathogens and Toll-Like Receptor Ligands following Infant Bacillus Calmette–Guérin Russia Vaccination (2017) (9)
Population-specific evolution of HIV Gag epitopes in genetically diverged patients. (2013) (9)
The presence of prolines in the flanking region of an immunodominant HIV‐2 gag epitope influences the quality and quantity of the epitope generated (2015) (9)
HIV: Tired T cells turn around (2006) (9)
The Changing Face of HIV and AIDS (2001) (8)
Impact of a single HLA-A*24:02-associated escape mutation on the detrimental effect of HLA-B*35:01 in HIV-1 control (2018) (8)
Survival with HIV infection: good luck or good breeding? (1998) (8)
HIV viral set point and host immune control in individuals with HIV-specific CD8+ T-cell responses prior to HIV acquisition (2010) (8)
KIR Gene Content Diversity in a Zimbabwean Population: Does KIR2DL2 Have a Role in Protection Against Human Immunodeficiency Virus Infection? (2016) (8)
Longitudinal Study of HIV gag-Specific Cytotoxic T Lymphocyte Responses over Time in Several Patients (1992) (8)
Clinical predictors cannot replace biological predictors in HIV-2 infection in a community setting in West Africa (2012) (8)
Editorial: Immune Mechanisms Underlying the Increased Morbidity and Mortality of HIV-Exposed Uninfected (HEU) Children (2017) (8)
Construction of an infectious HIV type 1 molecular clone from an African patient with a subtype D/C Recombinant Virus. (2004) (7)
How can we design better vaccines to prevent HIV infection in women? (2014) (7)
Chikungunya: out of the tropical forests and heading our way …. (2016) (7)
Pilot testing of an online training module about screening for acute HIV infection in adult patients seeking urgent healthcare (2018) (7)
Control of HIV co-receptor expression: implications for pathogenesis and treatment. (1997) (7)
CD 4 T Cell Responses to Cytomegalovirus in Early Life : A Prospective Birth Cohort Study (2008) (7)
Killer Cell Immunoglobulin-Like Receptor Genotypes and Haplotypes Contribute to Susceptibility to Hepatitis B Virus and Hepatitis C Virus Infection in Cameroon. (2020) (6)
Low Postseroconversion CD4+ T-cell Level Is Associated with Faster Disease Progression and Higher Viral Evolutionary Rate in HIV-2 Infection (2019) (6)
IL-15 re-programming compensates for NK cell mitochondrial dysfunction in HIV-1 infection (2019) (6)
Effect of HIV-2 infection on HIV-1 disease progression. (2012) (6)
Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2 (2020) (6)
Identification of KIR3DL1*0150208 using long-range sequence-based techniques. (2014) (6)
Faculty of 1000 evaluation for HIV-1 adaptation to HLA: a window into virus-host immune interactions. (2017) (6)
Limited Impact of Human Cytomegalovirus Infection in African Infants on Vaccine-Specific Responses Following Diphtheria-Tetanus-Pertussis and Measles Vaccination (2020) (6)
Genomic analysis of HIV type 1 strains derived from a mother and child pair of long-term nonprogressors. (2007) (6)
Identification of KIR3DL1*0050103 by the sequence-based techniques. (2013) (6)
Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation Trust (2021) (6)
Killer-cell immunoglobulin-like receptors associate with HIV-1 infection in a narrow-source Han Chinese cohort (2018) (6)
Dimers are a girl's best friend (1997) (6)
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV (2021) (6)
HIV-1-specific CD8 T cell responses in a pediatric slow progressor infected as a premature neonate. (2002) (5)
Reappearance of HIV antibody in an infected, seronegative individual after treatment with highly active antiretroviral therapy. (1999) (5)
Erratum: Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals (Journal of Clinical Investigation (2008) 118, 10, (3478-3490) doi:10.1172/JCI32460) (2012) (5)
8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
Human leukocyte antigen (HLA) B*18 and protection against mother-to-child HIV type 1 transmission. AIDS Res Hum Retroviruses . 2004 Jul; 20 ( 7 ): 692-7 (2004) (5)
HLA-associated polymorphisms in the HIV-2 capsid highlight key differences between HIV-1 and HIV-2 immune adaptation (2018) (5)
Structure of HIV-2 Nef Reveals Features Distinct from HIV-1 Involved in Immune Regulation (2019) (5)
Targeting TRIM5α in HIV Cure Strategies for the CRISPR-Cas9 Era (2017) (5)
A winding road towards an HIV vaccine. (2008) (5)
Variation of HLA class I (-A and -C) genes in individuals infected with hepatitis B or hepatitis C virus in Cameroon (2020) (5)
Report of a novel KIR3DS1*0130104 allele discovered using advanced molecular techniques. (2014) (4)
New insights are game-changers in HIV-2 disease management - Authors' reply. (2019) (4)
Prolonged CD8+ T-cell expansions after adoptive transfer of syngeneic lymphocytes between HIV-discordant identical twins. (1998) (4)
Differential remodeling of a T-cell transcriptome following CD8- versus CD3-induced signaling (2008) (4)
Erratum: Dynamics of T cell responses in HIV infection (The Journal of Immunology (2002) 168 (3660-3666)) (2002) (4)
Isolation of full‐length HLA‐C*18:02 allele in an individual from Sub‐Saharan Africa (2016) (4)
Low-Bias RNA Sequencing of the HIV-2 Genome from Blood Plasma (2018) (4)
Mature CD 8 + T lymphocyte response to viral infection during fetal life (2018) (4)
A 2 Amino Acid Shift in Position Leads to a Substantial Difference in the Pattern of Processing of 2 HIV-1 Epitopes (2012) (4)
Lessons from the failure of the adenovector HIV vaccine (2009) (3)
Role of antenatal plasma cytomegalovirus DNA levels on pregnancy outcome and HIV-1 vertical transmission among mothers in the University of Zimbabwe birth cohort study (UZBCS) (2021) (3)
Greater Expansion of IFN- γ ﹣ CD4 + NKT Cells in HIV-1 Compared with HIV-2-Infected Subjects with Preserved CD4 + T Cell Counts (2012) (3)
Full-length sequence of KIR3DL1*01501 allele found in Sub-Saharan Africa by long-range sequencing. (2014) (3)
Detection of broad functional gag-specific CD4+ T cell responses in HIV-1-infected subjects following therapeutic immunization with rMVA expressing an HIV-1 gag immunogen (2006) (3)
Faculty Opinions recommendation of Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. (2002) (3)
Analysis of HIV-1 envelope evolution suggests antibody-mediated selection of common epitopes among Chinese former plasma donors from a narrow-source outbreak (2018) (3)
AIDS pathogenesis: what have two decades of research taught us? (2004) (3)
HLA‐C*06:04:02 a novel HLA‐C allele isolated from donors of Southern African descent (2016) (3)
The protective effect of HIV-2 infection: implications for understanding HIV-1 immunity. (2014) (3)
HLA‐C*16:01:01:02, a recently isolated HLA class I allele from Southern Africa (2016) (3)
Future vaccines for HIV (1996) (3)
A Comprehensive Analysis of the Impact of HIV on HCV Immune Responses and Its Association with Liver Disease Progression in a Unique Plasma Donor Cohort (2016) (3)
A Stronger Innate Immune Response During Hyperacute Human Immunodeficiency Virus Type 1 (HIV-1) Infection Is Associated With Acute Retroviral Syndrome (2021) (3)
History of tuberculosis is associated with lower exhaled nitric oxide levels in HIV-infected children (2019) (3)
Identification of a novel HLA B*57 restricted cytotoxic T-lymphocyte epitope within HIV-1 rev (2006) (3)
Higher Type 1 Interferon Levels in Plasma of Asymptomatic HIV-2 than in HIV-1 Individuals (2016) (2)
KIR and HLA-C Genetic Polymorphisms Influence Plasma IP-10 Concentration in Antiretroviral Therapy-Naive HIV-Infected Adult Zimbabweans. (2019) (2)
Sex differences in immune responses to vaccines (2014) (2)
HLA allele distributions and associations in a cohort of LTNPs from China (2011) (2)
The 64I allele of the CCR2 chemokine receptor is strongly associated with delayed disease progression in a cohort of African prostitutes (1998) (2)
Delayed disease progression in HIV‐2: the importance of TRIM5α and the retroviral capsid (2019) (2)
EPITOPE VARIATION AND T-CELL RECOGNITION (1995) (2)
Killer-cell immunoglobulin-like receptor gene 3DL1*077 isolated using long-range sequence-based techniques. (2014) (2)
Soluble biomarkers associated with chronic lung disease in older children and adolescents with perinatal HIV infection. (2021) (2)
Proinflammatory and cardiovascular biomarkers are associated with echocardiographic abnormalities in children with HIV taking antiretroviral therapy (2022) (2)
Primary CMV infection: a co-factor HIV-1 disease progression in African infants? (2008) (2)
Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation Trust (2021) (2)
HIV: vaccines out of Africa. (2001) (2)
InfectionDistinguishes HIV-2 from HIV-1 Maintenance of HIV-Specific CD4+ T Cell (2013) (1)
HIV-2 gene product-specific T cell responses and viraemia control (2006) (1)
Assessing Training Needs of Clinical Officers to Target Acute HIV Infection Evaluation of Adult Patients Seeking Urgent Healthcare in Kenya (2016) (1)
Sensing our Z-RNA (2021) (1)
Vitamin D3 and calcium carbonate supplementation for adolescents with HIV to reduce musculoskeletal morbidity and immunopathology (VITALITY trial): study protocol for a randomised placebo-controlled trial (2021) (1)
Immune Mechanisms of Viral Control in HIV-2 Infection (2012) (1)
Identification of the KIR3DL1*0050105 allele by sequence-based techniques. (2014) (1)
Report of a novel activating killer-cell immunoglobulin-like receptor allele 3DS1*078 identified using sequence-based typing. (2014) (1)
AGGREGATION OF RANTES IS RESPONSIBLE FOR THE ACTIVATION OF LEUKOCYTES (1999) (1)
Cytomegalovirus-Specific Immunoglobulin G Is Associated With Chronic Lung Disease in Children and Adolescents from Sub-Saharan Africa Living With Perinatal Human Immunodeficiency Virus (2020) (1)
CD4 count recovery following initiation of HIV antiretroviral therapy in older childhood and adolescence Short title: CD4 count after ART start in adolescence (2018) (1)
HLA correlates in a cohort of slow progressors from China: effects on HIV-1 disease progression (2013) (1)
Associated with Long-Term Nonprogression Identification of Related HLAs Potentially HLA-B * 5703-Peptide Complexes and Structures of Three HIV-1 (2005) (1)
Faculty Opinions recommendation of Soluble HIV-1 Env trimers in adjuvant elicit potent and diverse functional B cell responses in primates. (2011) (1)
Immune approaches for the prevention of breast milk transmission of HIV-1. (2012) (1)
Identification of KIR3DL1*0200101 by long-range sequence-based techniques. (2014) (1)
"The effect of 48-weeks azithromycin therapy on levels of soluble biomarkers associated with HIV-associated chronic lung disease". (2023) (1)
Two novel KIR3DL1 alleles, 3DL1*0150205 and 3DL1*0150206, identified by full-length DNA sequencing. (2014) (1)
Dimorphism in the T-cell receptor constant region affects T-cell function, phenotype and HIV outcome. (2019) (1)
Detection of a novel killer-cell immunoglobulin-like receptor allele - KIR3DL1*0150207 - in Asian individuals. (2014) (1)
HLA-C*18:01 and KIR2DL2+C1 genetic variants are associated with low viral load in cART naïve HIV-infected adult Zimbabweans. (2018) (1)
Faculty Opinions recommendation of Peripheral CD4(+)CD8(+) T cells are differentiated effector memory cells with antiviral functions. (2004) (1)
Collaboration of a Detrimental HLA-B*35:01 Allele with HLA-A*24:02 in Coevolution of HIV-1 with T Cells Leading to Poorer Clinical Outcomes (2021) (1)
Faculty Opinions recommendation of Phase 2b controlled trial of M72/AS01E vaccine to prevent tuberculosis. (2018) (1)
Dynamics of T Cell Responses in HIV (2013) (1)
A novel KIR3DL1*0200102 allele isolated from a West African donor by sequence-based typing. (2014) (1)
A novel full‐length two‐domain KIR2DL5A allele isolated in Zimbabwean samples: KIR2DL5A*0010104 (2020) (1)
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study (2023) (1)
Anti-Retroviral Therapy (ART) Monitoring and the Development of the Oligonucleotide Ligation Assay for Detecting Critical Drug-resistant Mutations in HIV-2 Patients in Preparation of the Global Fund Initiative in The Gambia (2005) (1)
Decision letter: The HIV-1 latent reservoir is largely sensitive to circulating T cells (2020) (0)
KIR3DL1*0250103: a novel three-domain KIR allele isolated in West African samples. (2015) (0)
Human endogenous retroviruses (2003) (0)
The role of CD8+ T-cell responses in the pathogenesis of HIV-2, a naturally contained human retroviral infection (2013) (0)
CTL responses to HIV-1 during acute and chronic infection (2008) (0)
Faculty Opinions recommendation of Inhibitory KIR/HLA incompatibility between sexual partners confers protection against HIV-1 transmission. (2014) (0)
Polymorphisms in TRIM22 are associated with HIV-2 acquisition and disease progression (2015) (0)
Analysis of HIV-1 envelope evolution suggests antibody-mediated selection of common epitopes among Chinese former plasma donors from a narrow-source outbreak (2018) (0)
Faculty Opinions recommendation of Genotoxic signature in cord blood cells of newborns exposed in utero to a Zidovudine-based antiretroviral combination. (2013) (0)
Human leukocyte antigen (HLA) B*18 and protection against mother- to-child HIV type1 transmission (2004) (0)
F1000Prime recommendation of Persistent HIV-1 replication during antiretroviral therapy. (2017) (0)
P.377 Novel oligonucleotide assay detects HBV pre-core and basal core mutations in HBV-infected Gambians (2006) (0)
Analysis of H5N1 specific T cell responses in a high risk cohort in VietNam indicates possible asymptomatic infection (2010) (0)
Differential Expressions of Selected Activating and Inhibitory Receptors on K562-Stimulated Natural Killer (NK) Cells in HIV-1 and HIV-2 Infections (2015) (0)
Diagnosis of inflammatory demyelination in biopsy specimens : a . A Practical Approach (2014) (0)
Faculty Opinions recommendation of Next-Generation Sequencing to Help Monitor Patients Infected with HIV: Ready for Clinical Use? (2017) (0)
Correction: Resisting Immune Exhaustion in HIV-1 Infection (2008) (0)
A novel KIR3DL1*0070104 allele found in individuals from Asia. (2014) (0)
Human Leucocyte Antigen Supertypes And Immune Susceptibility To Hiv-1, Implications (2001) (0)
The Cellular Immune Response to HIV-2 Infection (2015) (0)
A new variant of killer-cell immunoglobulin-like receptor KIR3DL1*03101 isolated using sequence-based techniques. (2014) (0)
Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation Trust. (2021) (0)
Faculty Opinions recommendation of Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection. (2017) (0)
I-11 Towards an HIV vaccine—what is protective immunity against HIV infection? (2008) (0)
Natural alteration of HIV-1 co-receptor tropism by contemporaneous HIV-2 infection (2018) (0)
Control of HIV replication by CTL responses (1999) (0)
Faculty Opinions recommendation of TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection. (2012) (0)
Structural Characterization of HIV-2 Nef Protein (2016) (0)
ST111 Immune selection and vpu variability in a unique narrow source HIV-Positive village cohort (2013) (0)
Reply by authors. (2019) (0)
Crystal structure of HIV-2 Nef protein (2020) (0)
Faculty Opinions recommendation of Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. (2002) (0)
Late escape from an immunodominant cytotoxic T lymphocyte response associated with progression to AIDS (1997) (0)
Faculty Opinions recommendation of Follicular Helper T Cells Are Major Human Immunodeficiency Virus-2 Reservoirs and Support Productive Infection. (2020) (0)
Faculty Opinions recommendation of Molecular clock of HIV-1 envelope genes under early immune selection. (2017) (0)
TCR-Identical CD8+T-Cells Can Have Distinct Killing Efficacy Determined By Events Beyond the T-Cell Receptor (2017) (0)
The identification of a killer cell immunoglobulin-like receptor 3DL1*0150209 in an Asian population using molecular techniques. (2015) (0)
Detection of a novel KIR3DL1*0150210 allele by sequencing. (2015) (0)
Sex-Differential Impact of Human Cytomegalovirus Infection on In Vitro Reactivity to Toll-Like Receptor 2, 4 and 7/8 Stimulation in Gambian Infants (2020) (0)
Faculty Opinions recommendation of Greater CD8+ TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infection. (2003) (0)
Chronic Lung Disease in Patients With Perinatally Acquired HIV in England: A Retrospective Case-Note Review (2020) (0)
Dendritic cell function in HIV disease (2003) (0)
KIR3DL1*0250102: a novel three-domain KIR subtype identified in West Africa. (2015) (0)
Dendritic cell function in HIV disease (2003) (0)
TRIM22 genotype is not associated with markers of disease progression in children with HIV-1 infection (2021) (0)
Faculty Opinions recommendation of Prolonged activation of virus-specific CD8+T cells after acute B19 infection. (2005) (0)
Characterisation of immune responses within HLA-B*40+patients in a Chinese HIV-1 infected slow progressor cohort (2010) (0)
Faculty Opinions recommendation of Augmentation of HIV-specific T cell function by immediate treatment of hyperacute HIV-1 infection. (2019) (0)
Specificity of T-Cell Response, Not Protective HLA Restrictions, Determines Control of HIV Replication in Thai Viraemic Controllers (2013) (0)
Faculty Opinions recommendation of Minimal Contribution of APOBEC3-Induced G-to-A Hypermutation to HIV-1 Recombination and Genetic Variation. (2017) (0)
Faculty Opinions recommendation of Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. (2006) (0)
Full-length sequence of KIR3DL1*0310102 detected in DNA samples from West Africa. (2015) (0)
Mycobacterial Responses at 9 Months of Age Responses but Leads to Comparable Age Reduces Postvaccination Th1 and IL-17 Vaccination from Birth to 4 1/2 Months of Delaying Bacillus Calmette-Guérin (2010) (0)
) epidemiology of HIV-1 , HIV-2 and HTLV-1 in Guinea-Bissau (2011) (0)
Functional analysis of candidate CD8+T cell-derived anti-HIV factors (2005) (0)
Shorter Granulocyte Telomeres Among Children and Adolescents With Perinatally Acquired Human Immunodeficiency Virus Infection and Chronic Lung Disease in Zimbabwe (2020) (0)
Faculty Opinions recommendation of An immune basis for malaria protection by the sickle cell trait. (2005) (0)
Faculty Opinions recommendation of Inferring heterogeneous evolutionary processes through time: from sequence substitution to phylogeography. (2017) (0)
World AIDS Day 2007 — Let ' s Get Talking about a Vaccine (2007) (0)
Full length KIR3DS1*0130110 allele isolated by SBT. (2014) (0)
Anti-Retroviral Treatment Infected Patients before and after Responses to Tuberculosis Antigens in HIV-1 T Cell + and CD8 + Polyfunctional CD4 (2010) (0)
Faculty Opinions recommendation of Human immunodeficiency virus-specific CD8(+) T cells in human breast milk. (2002) (0)
The immunological effects of co-administering diphtheria, tetanus, pertussis combined vaccine with measles vaccine to 9 month old Gambian infants (2011) (0)
Faculty Opinions recommendation of Structure of an HIV-2 gp120 in Complex with CD4. (2016) (0)
KIR3DS1*0130109: a novel activating three-domain KIR identified using sequence-based typing. (2015) (0)
Vaccinia virus strain modified virus Ankara: Characterisation of cytokine receptor profile, virological features, and use as an immunological reagent (1997) (0)
Phenotypic characterization of HIV-specific CD8 T cells during acute infant HIV infection (2009) (0)
In cooperation we trust (2000) (0)
Human Immunodeficiency Virus Type 1 Clades Patients Frequently Cross-React with Different Immunodeficiency Virus Type 2-Infected Cytotoxic T Cells from Human (2014) (0)
Viral evolution in infant HIV infection (2018) (0)
Evolutionary Dynamics of HIV-2 Infection in a Community Cohort of West Africa (2009) (0)
The role of Hiv specific Ctl in Hiv infection (1993) (0)
Type 1 -Defective HIV nef Patients Infected with Activity in Sydney Blood Bank Cohort (HIV)-Specific Cytotoxic T-Lymphocyte Strong Human Immunodeficiency Virus (2014) (0)
Lung immunology in AIDS patients (1997) (0)
Definition of the early HIV-1 signalosome in dendritic cells (2013) (0)
Vigorous HIV-Specific CD4 T Cell Responses in IIIV-1 Infected African Children and Adults in the Absence of Antiretroviral Therapy (2002) (0)
Carriers Cells Specific for EBV in Healthy Virus T + A Re-Evaluation of the Frequency of CD 8 (1999) (0)
Botswana's painful journey (2010) (0)
A novel full length KIR3DL1*0070103 identified by molecular typing. (2013) (0)
InfectionDynamics of T Cell Responses in HIV (0)
Faculty Opinions recommendation of Human Cytomegalovirus Enhances Placental Susceptibility and Replication of Human Immunodeficiency Virus Type 1 (HIV-1), Which May Facilitate In Utero HIV-1 Transmission. (2018) (0)
The T Lymphocyte Response to HIV: Molecular Basis for Immune Recognition and Escape (1993) (0)
Faculty of 1000 evaluation for HCMV enhances placental susceptibility and replication of HIV-1 which may facilitate in utero HIV-1 transmission. (2018) (0)
HIV-1-Infected Kenyan Children Correlates of Delayed Disease Progression in (2005) (0)
MECHANISM OF MHC-MEDIATED ANTIGEN RECOGNITION BY T-CELLS (1993) (0)
Isolation of full-length genomic sequences of the KIR3DL1*0040103 allele from African donors using sequence-based techniques. (2014) (0)
A Pilot Study of the Safety and Inununogenicity of An HIV-1 Clade a Gag/Multiepitope DNA Vaccine, pTHr.HIVA, in HIV-1 Seropositive Subjects Receiving Highly Active Antiretroviral Therapy (2003) (0)
KIR3DS1*0130108 isolated using full length sequence-based typing. (2014) (0)
Description of a novel KIR3DL1*0050104 allele identified using sequence-based techniques. (2014) (0)
Faculty Opinions recommendation of Increased Risk of HIV Acquisition Among Women Throughout Pregnancy and During the Postpartum Period: A Prospective Per-Coital-Act Analysis Among Women With HIV-Infected Partners. (2018) (0)
Immune activation markers and CMV DNA-aemia in children with perinatally acquired HIV infection (2019) (0)
InfectionDistinguishes HIV-2 from HIV-1 T Cell + Maintenance of HIV-Specific CD4 (2017) (0)
A17 The effect of intra-host evolution of HIV-2 capsid on disease progression (2019) (0)
Children with Dengue to Commencement of Capillary Leakage in T Cell Responses in Relation + Timing of CD8 (2010) (0)
P20-19 LB. Extensive HLA-driven viral diversity following a single-source HIV-1 outbreak in rural China (2009) (0)
The first crystal structure of HIV-2 Nef protein (2017) (0)
Crystal structure of SIVmac239 Nef protein (2020) (0)
Reply to Cevik et al (2019) (0)
Faculty Opinions recommendation of Error rates, PCR recombination, and sampling depth in HIV-1 whole genome deep sequencing. (2017) (0)
Escafe from immune control by HIV (1997) (0)
HIV-1-Infected Infants Responses during the First Year of Life in ( HIV-1 )-Specific Gamma Interferon Immunodeficiency Virus Type 1 Longitudinal Assessment of Human (2005) (0)
HLA-B27 SUBTYPING BY SINGLE-STRAND CONFORMATION POLYMORPHISMS (SSCP) IN CAUCASOIDS, NEGROIDS AND INUITS FROM GREENLAND (1992) (0)
Faculty Opinions recommendation of Bayesian inference of infectious disease transmission from whole-genome sequence data. (2017) (0)
P069UTR SNPS rs111686073 and rs73410010 independently modify expression of tapasin in blacks (2018) (0)
KIR3DS1*0130111: a novel KIR allele identified using molecular typing methods. (2015) (0)
A35 Viral evolution and innate immune responses during acute HIV-1 infection and their association with disease pathogenesis (2017) (0)
Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation Trust. (2022) (0)
Lung Immunology and HIV (1997) (0)
Spectrum and kinetic of T cell responses to dengue virus epitopes and the influence of hla polymorphisms in dengue disease pathogenesis (2006) (0)
Faculty Opinions recommendation of Extremely High Mutation Rate of HIV-1 In Vivo. (2017) (0)
Prevalence and Magnitude of HIV-1-specific Lymphocyte Responses in Breast Milk from HIV-1 Seropositive Women. J Infect Dis. 2003:188:1 (2003) (0)
The use of tetramers in the quantitative analysis of T-cell responses (2002) (0)
Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens (2023) (0)
139 HIV-2 Capsids Distinguishing High and Low Virus Load Patients in a West African Community Cohort (2009) (0)
The KIR3DS1*0130105 allele identified using high-resolution sequence-based typing. (2014) (0)
Reply by Authors. (2018) (0)
Frequent Inter-Subytpe Recombination Detected in Complete HIV-1 RNA Sequences From Highly Exposed Kenyan Women (2000) (0)
Reply to authors. (2018) (0)
SpondyloarthropathiesRole in Susceptibility to Pocket Suggests a Novel Mechanism for Its Misfolding of HLA-B27 as a Result of Its B (1999) (0)
in HIV-1-Infected Infants Activated and Apoptosis-Vulnerable T Cells Associated with Increased Frequencies of Acute Cytomegalovirus Infection Is (2012) (0)
KIR3DL1*0040102 – a novel three-domain KIR subtype isolated from donors of African descent. (2015) (0)
Comparison of Cytotoxic activity and Interferon-g secretion by Natural Killer Cells in HIV-1 and HIV-2 infected individuals (2010) (0)
Chronic lung disease in HIV-infected children established on antiretroviral 1 therapy 2 (2018) (0)
Genome-wide profiling of humoral immunity and pathogen genes under selection identifies immune evasion tactics of Chlamydia trachomatis during ocular infection (2017) (0)
Faculty Opinions recommendation of Virtual memory CD8+ T cells restrain the viral reservoir in HIV-1-infected patients with antiretroviral therapy through derepressing KIR-mediated inhibition. (2020) (0)
Faculty Opinions recommendation of Anatomical loci of HIV-associated immune activation and association with viraemia. (2003) (0)
KIR gene content diversity in a Zimbabwean population : Does KIR 2 DL 2 have a role in protection against HIV infection ? (2017) (0)
MIP-3 alpha does not appear to play an important role in amplifying human infection with HIV-1 in the female genital tract (2018) (0)
Faculty Opinions recommendation of Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing. (2016) (0)
Correction. The presence of prolines in the flanking region of an immunodominant HIV-2 gag epitope influences the quality and quantity of the epitope generated. (2015) (0)
High pro-inflammatory cytokine secretion and selective depletion of high avidity cross-reactive cytotoxic T-cells in the pathogenesis of acute secondary dengue virus infection (2007) (0)
Faculty Opinions recommendation of CD8 T cell response and evolutionary pressure to HIV-1 cryptic epitopes derived from antisense transcription. (2010) (0)
Faculty Opinions recommendation of Selective accumulation of differentiated CD8+ T cells specific for respiratory viruses in the human lung. (2006) (0)
Immune Escape in Hiv Infection (1995) (0)
Genomic full length sequence of a novel killer-cell immunoglobulin-like receptor, KIR3DL1*0010103 identified by sequencing. (2014) (0)
Uninfected African Children (2019) (0)
Distinct antibody-mediated selection in a narrow-source HIV-1 outbreak among Chinese former plasma donors (2017) (0)
HLA-B51 associated HIV-1 viral control (2013) (0)
HIV Immunity and 'Resistant' Sex Workers: An Interview with Sarah Rowland-Jones (2001) (0)
A novel full-length KIR3DS1*0130106 allele identified by sequencing. (2014) (0)
Development and evaluation of the oligonucleotide ligation assay (OLA) for the detection of drug resistance mutations in HIV-2 patients on antiretroviral therapy (2006) (0)
Impaired Effect of HLA-A*24: 02-associated Mutation on HLA-B*35: 01-associated HIV-1 Control (2016) (0)
The Role of Cytotoxic Lymphocytes in HIV Infection (1992) (0)
A novel KIR3DL1*0150103 subtype identified in West Africa. (2015) (0)
Faculty Opinions recommendation of HLA-B*35-Px-mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulses. (2010) (0)
Long-range sequencing revealed a new KIR3DL1*0150204 allele in 20 individuals of Asian descent. (2014) (0)
Anti-CD8 antibody induced transcriptional remodelling in HIV-specific CD8 T cells secreting Anti-HIV-1 factors (2004) (0)
Description of a novel KIR3DL1*0150211 allele isolated using molecular techniques. (2014) (0)
Killer-cell immunoglobulin-like receptor (KIR) genetic diversity in a unique HIV-1 cohort in China (2014) (0)

This paper list is powered by the following services:

Sarah Louise Rowland-jones's Academic­Influence.com Rankings

Sarah Louise Rowland-jones's Degrees

Why Is Sarah Louise Rowland-jones Influential?

Sarah Louise Rowland-jones's Published Works

Published Works

Sarah Louise Rowland-jones's AcademicInfluence.com Rankings